63 /100
HIGH RISK
Score updated Apr 13, 2026

SER

Serina Therapeutics, Inc. — Stock Dilution Tracker

Track SER dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

🔔 Track SER — Get alerts when the score changes →
📊 Score Breakdown
📋 Offering Ability
40
💰 Cash Runway
85
📊 Float Risk
55
⚠️ Warrant Exposure
15
🔄Convertible Debt
🌦️ Dilution Forecast
🌥️
Advisory
Moderate dilution signals present
33%
🔁 Convertible Conversion 40%
• Significant convertible debt: 20% potential dilution
• Elevated convertible risk (60/100)
💰 Capital Raise 35%
• Low cash runway: 3 months remaining
🔄 Reverse Split 15%
• Only 3 months cash — financial pressure
🔔 Track SER — Get forecast alerts →
💹 Market Data
Market Cap$24.38M
Shares Outstanding12.31M
Float6.84M
Cash$3.06M
Debt$3.32M
Short InterestN/A
🏛 Institutional Holdings
10 institutional holders · 425.0K shares
#1 Vanguard Group Inc 180.0K shares
#2 Waverly Advisors, LLC 67.5K shares
#3 Broadwood Capital, Inc. 54.5K shares
+ 7 more holders Sign up free to view →
📉 Short Interest
Short Interest478.1K
Days to Cover1.0
% of Float7.0%
FINRA data as of Mar 31, 2026
📁 Recent SEC Activity
xbrl XBRL CONVERTIBLE Dec 31, 2025
xbrl XBRL WARRANT Dec 31, 2025
Form 4 INSIDER TRANSACTION Mar 23, 2026
Form 4 INSIDER TRANSACTION Mar 19, 2026
Form 4 INSIDER TRANSACTION Feb 02, 2026
Full SEC filing analysis available with free account
📰 Recent News
No recent news
Track SER Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking SER — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required